Edgar Filing: ENDO PHARMACEUTICALS HOLDINGS INC

Ownership Submission

FORM 4

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:

3235-0287

Expires:

January 31, 2005

Estimated average burden hours per response...

0.5

(Print or Type Responses)

1. Name and Address of Reporting Person ^*

LEE DAVID A H

2. Issuer Name and Ticker or Trading Symbol
ENDO PHARMACEUTICALS HOLDINGS INC [ENDP]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

_____ Director	_____ 10% Owner
__X__ Officer (give title below)	_____ Other (specify below)
Exec. V.P and CSO

(Last)

(First)

(Middle)

100 PAINTERS DRIVE

3. Date of Earliest Transaction (Month/Day/Year)
10/12/2005

(Street)

CHADDS FORD, PA 19317

4. If Amendment, Date Original Filed(Month/Day/Year)

6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

(City)

(State)

(Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1.Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1.Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock, par value $.01 per share	10/12/2005		M		93,000	A	$ 3.42	93,000	D
Common Stock, par value $.01 per share	10/12/2005		M		302,246	A	$ 2.42	395,246	D
Common Stock, par value $.01 per share	10/12/2005		M		541,971	A	$ 3	937,217	D
Common Stock, par value $.01 per share	10/12/2005		M		32,325	A	$ 2.42	969,542	D
Common Stock, par value $.01 per share	10/12/2005		M		621,468	A	$ 3	1,591,010	D
Common Stock, par value $.01 per share	10/12/2005		M		408,087	A	$ 2.42	1,999,097	D
Common Stock, par value $.01 per share	10/12/2005		M		613,647	A	$ 3	2,612,744	D
Common Stock, par value $.01 per share	10/12/2005		M		339,305	A	$ 2.42	2,952,049	D
Common Stock, par value $.01 per share	10/12/2005		S		1,777,512	D	$ 26.04	1,174,537	D

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.		SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security
(Instr. 3)

2. Conversion or Exercise Price of Derivative Security

3. Transaction Date (Month/Day/Year)

3A. Deemed Execution Date, if any (Month/Day/Year)

4. Transaction Code
(Instr. 8)

5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)

6. Date Exercisable and Expiration Date
(Month/Day/Year)

7. Title and Amount of Underlying Securities
(Instr. 3 and 4)

8. Price of Derivative Security
(Instr. 5)

9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)

10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)

11. Nature of Indirect Beneficial Ownership
(Instr. 4)

Code

(A)

(D)

Date Exercisable

Expiration Date

Title

Amount or Number of Shares

Class C1A Stock Option

$ 3.42

10/12/2005

93,000

10/12/2005⁽¹⁾

08/26/2007

Common Stock ⁽²⁾

93,000

$ 0

Class C1B Stock Option

$ 2.42

10/12/2005

302,246

10/12/2005⁽¹⁾

08/26/2007

Common Stock ⁽²⁾

302,246

$ 0

Class C2 Stock Option

$ 3

10/12/2005

541,971

10/12/2005⁽¹⁾

08/26/2007

Common Stock ⁽²⁾

541,971

$ 0

Class C2 Stock Option

$ 2.42

10/12/2005

32,325

10/12/2005⁽¹⁾

08/26/2007

Common Stock ⁽²⁾

32,325

$ 0

Class C3 Stock Option

$ 3

10/12/2005

621,468

10/12/2005⁽¹⁾

08/26/2007

Common Stock ⁽²⁾

621,468

$ 0

Class C3 Stock Option

$ 2.42

10/12/2005

408,087

10/12/2005⁽¹⁾

08/26/2007

Common Stock ⁽²⁾

408,087

$ 0

Class C4 Stock Option

$ 3

10/12/2005

613,647

10/12/2005⁽¹⁾

08/26/2007

Common Stock ⁽²⁾

613,647

$ 0

Class C4 Stock Option

$ 2.42

10/12/2005

339,305

10/12/2005⁽¹⁾

08/26/2007

Common Stock ⁽²⁾

339,305

$ 0

Reporting Owners

Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
LEE DAVID A H 100 PAINTERS DRIVE CHADDS FORD, PA 19317			Exec. V.P and CSO

Signatures

/s/ David A.H. Lee		10/14/2005
^**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	The exercisability of the Stock Options was accelerated in connection with an offering of shares that closed on October 12, 2005.
(2)	Common Stock held by Endo Pharma LLC. The exercise of these stock options did not result in the issuance of additional Common Stock by the Issuer.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.